Does PEMBROLIZUMAB Cause Hyperthyroidism? 780 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 780 reports of Hyperthyroidism have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.9% of all adverse event reports for PEMBROLIZUMAB.
780
Reports of Hyperthyroidism with PEMBROLIZUMAB
0.9%
of all PEMBROLIZUMAB reports
61
Deaths
326
Hospitalizations
How Dangerous Is Hyperthyroidism From PEMBROLIZUMAB?
Of the 780 reports, 61 (7.8%) resulted in death, 326 (41.8%) required hospitalization, and 43 (5.5%) were considered life-threatening.
Is Hyperthyroidism Listed in the Official Label?
Yes, Hyperthyroidism is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Hyperthyroidism?
LEVOTHYROXINE (1,681)
AMIODARONE (1,410)
NIVOLUMAB (934)
IPILIMUMAB (525)
CARBOPLATIN (432)
ATEZOLIZUMAB (416)
PACLITAXEL (261)
ALEMTUZUMAB (236)
LENVATINIB (231)
PREDNISONE (220)
Which PEMBROLIZUMAB Alternatives Have Lower Hyperthyroidism Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G